AICAR Blocks the Proliferation of Pulmonary Artery Smooth Muscle Cells by Inhibition of Cell Cycle in G0/G1
10.11969/j.issn.1673-548X.2015.05.030
- VernacularTitle:AMPK激动剂AICAR通过阻滞细胞周期于G0 /G1 期抑制肺动脉平滑肌细胞增殖
- Author:
Wenjun GUAN
;
Chenhong XU
- Publication Type:Journal Article
- Keywords:
AMPK;
PDGF-BB;
Pulmonary artery smooth muscle cells;
Cell cycle;
Proliferation
- From:
Journal of Medical Research
2015;44(5):111-113
- CountryChina
- Language:Chinese
-
Abstract:
Objective To establish the PDGF-BB-induced proliferation of rat pulmonary artery smooth muscle cells(PASMCs), and investigate the effects of the AMPK agonist AICAR on the cell cycle of PASMCs, in order to search new drugs for prevention of pulmo-nary vascular remodeling. Methods 20ng/ml PDGF-BB was used to induced the proliferation of PASMCs, and the effect of 0. 5mmol/L AICAR on the proliferation of PASMCs was observed. Western blot was used to detect the total and phosphorylated AMPK. The prolifer-ation of PASMCs was determined by CCK-8. The mRNA expression of cyclinD1, cyclinE and CDK2/4/6 were detected by flow cytometry analysis cell cycle,quantitative real-time PCR. Results Western blot Results indicated AICAR could promote the activation of AMPK. CCK-8 test Results showed that AICAR blocked the proliferation of PASMCs induced by PDGF-BB. Flow cytometry analysis indicated that AICAR arrested the cell cycle in G0/G1 to S phase. RT-PCR Results demonstrated that AICAR inhibited the mRNA expression of cy-clinD1, cyclinE and CDK2/4/6. Conclusion The AMPK agonist AICAR can block the proliferation of PASMCs induced through arrest cell cycle in G0/G1-S phase by regulation the mRNA expression of cyclin D1, cyclinE, CDK2/4/6, and AICAR has a potential applica-tion in preventing pulmonary vascular remodeling.
